Logo image of CLMT

CALUMET INC (CLMT) Stock Fundamental Analysis

USA - NASDAQ:CLMT - US1314281049 - Common Stock

17.95 USD
-0.23 (-1.27%)
Last: 10/10/2025, 11:40:06 AM
Fundamental Rating

1

CLMT gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 211 industry peers in the Oil, Gas & Consumable Fuels industry. Both the profitability and financial health of CLMT have multiple concerns. CLMT does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

In the past year CLMT has reported negative net income.
CLMT had a negative operating cash flow in the past year.
In the past 5 years CLMT reported 4 times negative net income.
The reported operating cash flow has been mixed in the past 5 years: CLMT reported negative operating cash flow in multiple years.
CLMT Yearly Net Income VS EBIT VS OCF VS FCFCLMT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M -400M

1.2 Ratios

The Return On Assets of CLMT (-16.25%) is worse than 89.57% of its industry peers.
Industry RankSector Rank
ROA -16.25%
ROE N/A
ROIC N/A
ROA(3y)-4.08%
ROA(5y)-6.46%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CLMT Yearly ROA, ROE, ROICCLMT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 -100

1.3 Margins

In the last couple of years the Operating Margin of CLMT has declined.
The Profit Margin and Operating Margin and Gross Margin are not available for CLMT so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5Y-41.55%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CLMT Yearly Profit, Operating, Gross MarginsCLMT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10

0

2. Health

2.1 Basic Checks

CLMT does not have a ROIC to compare to the WACC, probably because it is not profitable.
CLMT has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, CLMT has more shares outstanding
CLMT has a worse debt/assets ratio than last year.
CLMT Yearly Shares OutstandingCLMT Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
CLMT Yearly Total Debt VS Total AssetsCLMT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

2.2 Solvency

Based on the Altman-Z score of 0.37, we must say that CLMT is in the distress zone and has some risk of bankruptcy.
CLMT's Altman-Z score of 0.37 is on the low side compared to the rest of the industry. CLMT is outperformed by 65.40% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z 0.37
ROIC/WACCN/A
WACC10.32%
CLMT Yearly LT Debt VS Equity VS FCFCLMT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B 1.5B 2B

2.3 Liquidity

CLMT has a Current Ratio of 0.76. This is a bad value and indicates that CLMT is not financially healthy enough and could expect problems in meeting its short term obligations.
CLMT has a Current ratio of 0.76. This is in the lower half of the industry: CLMT underperforms 72.51% of its industry peers.
A Quick Ratio of 0.45 indicates that CLMT may have some problems paying its short term obligations.
The Quick ratio of CLMT (0.45) is worse than 87.20% of its industry peers.
Industry RankSector Rank
Current Ratio 0.76
Quick Ratio 0.45
CLMT Yearly Current Assets VS Current LiabilitesCLMT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

3

3. Growth

3.1 Past

CLMT shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -1756.25%.
CLMT shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -22.79%.
Measured over the past years, CLMT shows a small growth in Revenue. The Revenue has been growing by 3.94% on average per year.
EPS 1Y (TTM)-1756.25%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-254.17%
Revenue 1Y (TTM)-22.79%
Revenue growth 3Y9.99%
Revenue growth 5Y3.94%
Sales Q2Q%-9.45%

3.2 Future

CLMT is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 29.17% yearly.
Based on estimates for the next years, CLMT will show a small growth in Revenue. The Revenue will grow by 7.25% on average per year.
EPS Next Y-67.84%
EPS Next 2Y33.24%
EPS Next 3Y24.72%
EPS Next 5Y29.17%
Revenue Next Year1.05%
Revenue Next 2Y2.04%
Revenue Next 3Y7.23%
Revenue Next 5Y7.25%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
CLMT Yearly Revenue VS EstimatesCLMT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2B 4B 6B
CLMT Yearly EPS VS EstimatesCLMT Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 2 -2 4 -4

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CLMT. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for CLMT. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CLMT Price Earnings VS Forward Price EarningsCLMT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 -20 -30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CLMT Per share dataCLMT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 -10 20 30 40

4.3 Compensation for Growth

A more expensive valuation may be justified as CLMT's earnings are expected to grow with 24.72% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y33.24%
EPS Next 3Y24.72%

0

5. Dividend

5.1 Amount

CLMT does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

CALUMET INC

NASDAQ:CLMT (10/10/2025, 11:40:06 AM)

17.95

-0.23 (-1.27%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)08-08 2025-08-08/bmo
Earnings (Next)11-06 2025-11-06
Inst Owners51.5%
Inst Owner Change0%
Ins Owners2.93%
Ins Owner Change-1.79%
Market Cap1.56B
Analysts78.33
Price Target20.46 (13.98%)
Short Float %13.38%
Short Ratio10.43
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-377.07%
Min EPS beat(2)-407.62%
Max EPS beat(2)-346.52%
EPS beat(4)1
Avg EPS beat(4)-194.87%
Min EPS beat(4)-407.62%
Max EPS beat(4)30.36%
EPS beat(8)4
Avg EPS beat(8)85.48%
EPS beat(12)5
Avg EPS beat(12)-504.19%
EPS beat(16)6
Avg EPS beat(16)-374.79%
Revenue beat(2)2
Avg Revenue beat(2)9.05%
Min Revenue beat(2)8.78%
Max Revenue beat(2)9.31%
Revenue beat(4)4
Avg Revenue beat(4)7.51%
Min Revenue beat(4)0.99%
Max Revenue beat(4)10.98%
Revenue beat(8)8
Avg Revenue beat(8)8.83%
Revenue beat(12)11
Avg Revenue beat(12)8.29%
Revenue beat(16)15
Avg Revenue beat(16)10.55%
PT rev (1m)0%
PT rev (3m)0.31%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-50.82%
EPS NY rev (1m)-6.67%
EPS NY rev (3m)-91.16%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)7.98%
Revenue NY rev (1m)0%
Revenue NY rev (3m)4.96%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.38
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-5.94
EYN/A
EPS(NY)-0.59
Fwd EYN/A
FCF(TTM)-2.3
FCFYN/A
OCF(TTM)-1.46
OCFYN/A
SpS46.92
BVpS-11.64
TBVpS-11.64
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -16.25%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-4.08%
ROA(5y)-6.46%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)8.9%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5Y-41.55%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover1.47
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 48.93%
Cap/Sales 1.79%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.76
Quick Ratio 0.45
Altman-Z 0.37
F-Score2
WACC10.32%
ROIC/WACCN/A
Cap/Depr(3y)260.7%
Cap/Depr(5y)180.19%
Cap/Sales(3y)6.59%
Cap/Sales(5y)4.87%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-1756.25%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-254.17%
EPS Next Y-67.84%
EPS Next 2Y33.24%
EPS Next 3Y24.72%
EPS Next 5Y29.17%
Revenue 1Y (TTM)-22.79%
Revenue growth 3Y9.99%
Revenue growth 5Y3.94%
Sales Q2Q%-9.45%
Revenue Next Year1.05%
Revenue Next 2Y2.04%
Revenue Next 3Y7.23%
Revenue Next 5Y7.25%
EBIT growth 1Y-186.36%
EBIT growth 3YN/A
EBIT growth 5Y-39.24%
EBIT Next Year2694.27%
EBIT Next 3Y276.96%
EBIT Next 5Y146.58%
FCF growth 1Y66.94%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-227.06%
OCF growth 3YN/A
OCF growth 5YN/A